TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours

Cited in:

CrossRef

This article has been cited by:

1. 1
   M. Hollstein, M. Moriya, A.P. Grollman, M. Olivier, Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid, Mutation Research/Reviews in Mutation Research, 2013,

   CrossRef

2. You have free access to this content2
   Arthur P. Grollman, Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease, Environmental and Molecular Mutagenesis, 2013, 54, 1

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(471K)
   • References
3. 3
   Dana Nitzsche, Matthias F. Melzig, Volker M. Arlt, Evaluation of the cytotoxicity and genotoxicity of aristolochic acid I – A component of Aristolochiaceae plant extracts used in homeopathy, Environmental Toxicology and Pharmacology, 2013, 35, 2, 325

   CrossRef

4. 4
   Byeong Hwa Yun, Thomas A. Rosenquist, Jovan Nikolić, Dejan Dragičević, Karla Tomić, Bojan Jelaković, Kathleen G. Dickman, Arthur P. Grollman, Robert J. Turesky, Human Formalin-Fixed Paraffin-Embedded Tissues: An Untapped Specimen for Biomonitoring of Carcinogen DNA Adducts by Mass Spectrometry, Analytical Chemistry, 2013, 85, 9, 4251

   CrossRef

5. 5
   Maria Lina Tornesello, Luigi Buonaguro, Franco M. Buonaguro, Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: A systematic review, Gynecologic Oncology, 2013, 128, 3, 442

   CrossRef

6. 6
   J. Nortier, A. Pozdzik, T. Roumeguere, J.-L. Vanherweghem, Néphropathie aux acides aristolochiques (« néphropathie aux herbes chinoises »), EMC - Néphrologie, 2013, 10, 2, 1

   CrossRef

7. 7
   Frantisek Malir, Vladimir Ostry, Eva Novotna, Toxicity of the mycotoxin ochratoxin A in the light of recent data, Toxin Reviews, 2013, 32, 2, 19

   CrossRef

8. 8
   Lois A. Haighton, Barry S. Lynch, Bernadene A. Magnuson, Earle R. Nestmann, A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model, Critical Reviews in Toxicology, 2012, 42, 2, 147

   CrossRef

9. 9
   Yiying Wang, Volker M. Arlt, Candice A. Roufosse, Karen L. McKim, Meagan B. Myers, David H. Phillips, Barbara L. Parsons, ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues, Environmental and Molecular Mutagenesis, 2012, 53, 7

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(579K)
   • References
10. 10
    Byeong Hwa Yun, Thomas A. Rosenquist, Viktoriya Sidorenko, Charles R. Iden, Chung-Hsin Chen, Yeong-Shiau Pu, Radha Bonala, Francis Johnson, Kathleen G. Dickman, Arthur P. Grollman, Robert J. Turesky, Biomonitoring of Aristolactam-DNA Adducts in Human Tissues Using Ultra-Performance Liquid Chromatography/Ion-Trap Mass Spectrometry, Chemical Research in Toxicology, 2012, 25, 5, 1119

    CrossRef

11. 11
    Quan-Xiang Wei, Franciscus van der Hoeven, Monica Hollstein, Adam F Odell, Efficient introduction of specific TP53 mutations into mouse embryonic fibroblasts and embryonic stem cells, Nature Protocols, 2012, 7, 6, 1145

    CrossRef

12. 12
    Heinz H. Schmeiser, Jill E. Kucab, Volker M. Arlt, David H. Phillips, Monica Hollstein, Gheorghe Gluhovschi, Cristina Gluhovschi, Mirela Modilca, Liviu Daminescu, Ligia Petrica, Silvia Velciov, Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania, Environmental and Molecular Mutagenesis, 2012, 53, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1128K)
    • References
13. 13
    C.-H. Chen, K. G. Dickman, M. Moriya, J. Zavadil, V. S. Sidorenko, K. L. Edwards, D. V. Gnatenko, L. Wu, R. J. Turesky, X.-R. Wu, Y.-S. Pu, A. P. Grollman, From the Cover: Aristolochic acid-associated urothelial cancer in Taiwan, Proceedings of the National Academy of Sciences, 2012, 109, 21, 8241

    CrossRef

14. 14
    Musaffe Tuna, Christopher I. Amos, Genomic sequencing in cancer, Cancer Letters, 2012,

    CrossRef

15. 15
    Jill E. Kucab, David H. Phillips, Volker M. Arlt, Metabolic activation of diesel exhaust carcinogens in primary and immortalized human TP53 knock-in (Hupki) mouse embryo fibroblasts, Environmental and Molecular Mutagenesis, 2012, 53, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1244K)
    • References
16. 16
    L. Patrice McDaniel, Elizabeth R. Elander, Xiaoqing Guo, Tao Chen, Volker M. Arlt, Nan Mei, Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats , Environmental and Molecular Mutagenesis, 2012, 53, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(143K)
    • References
17. 17
    Serena Nik-Zainal, Ludmil B. Alexandrov, David C. Wedge, Peter Van Loo, Christopher D. Greenman, Keiran Raine, David Jones, Jonathan Hinton, John Marshall, Lucy A. Stebbings, Andrew Menzies, Sancha Martin, Kenric Leung, Lina Chen, Catherine Leroy, Manasa Ramakrishna, Richard Rance, King Wai Lau, Laura J. Mudie, Ignacio Varela, David J. McBride, Graham R. Bignell, Susanna L. Cooke, Adam Shlien, John Gamble, Ian Whitmore, Mark Maddison, Patrick S. Tarpey, Helen R. Davies, Elli Papaemmanuil, Philip J. Stephens, Stuart McLaren, Adam P. Butler, Jon W. Teague, Göran Jönsson, Judy E. Garber, Daniel Silver, Penelope Miron, Aquila Fatima, Sandrine Boyault, Anita Langerød, Andrew Tutt, John W.M. Martens, Samuel A.J.R. Aparicio, Åke Borg, Anne Vincent Salomon, Gilles Thomas, Anne-Lise Børresen-Dale, Andrea L. Richardson, Michael S. Neuberger, P. Andrew Futreal, Peter J. Campbell, Michael R. Stratton, Mutational Processes Molding the Genomes of 21 Breast Cancers, Cell, 2012, 149, 5, 979

    CrossRef

18. 18
    M. Lukin, T. Zaliznyak, F. Johnson, C. de los Santos, Structure and stability of DNA containing an aristolactam II-dA lesion: implications for the NER recognition of bulky adducts, Nucleic Acids Research, 2012, 40, 6, 2759

    CrossRef

19. 19
    Magali Olivier, Monica Hollstein, Heinz Hans Schmeiser, Kurt Straif, Christopher P. Wild, Upper urinary tract urothelial cancers: where it is A:T, Nature Reviews Cancer, 2012, 12, 8, 503

    CrossRef

20. 20
    Y. Wang, F. Meng, V. M. Arlt, N. Mei, T. Chen, B. L. Parsons, Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction, Mutagenesis, 2011, 26, 5, 619

    CrossRef

21. 21
    Volker M. Arlt, Jie Zuo, Kristina Trenz, Candice A. Roufosse, Graham M. Lord, Joelle L. Nortier, Heinz H. Schmeiser, Monica Hollstein, David H. Phillips, Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice, International Journal of Cancer, 2011, 128, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1002K)
    • References
22. 22
    K. Levova, M. Moserova, V. Kotrbova, M. Sulc, C. J. Henderson, C. R. Wolf, D. H. Phillips, E. Frei, H. H. Schmeiser, J. Mares, V. M. Arlt, M. Stiborova, Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model, Toxicological Sciences, 2011, 121, 1, 43

    CrossRef

23. 23
    Volker M. Arlt, Kateřina Levová, František Bárta, Zhanquan Shi, James D. Evans, Eva Frei, Heinz H. Schmeiser, Daniel W. Nebert, David H. Phillips, Marie Stiborová, Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies inCyp1a1(−/−),Cyp1a2(−/−), andCyp1a1/1a2(−/−)Mice, Chemical Research in Toxicology, 2011, 24, 10, 1710

    CrossRef

24. 24
    Marie Stiborová, Jaroslav Mareîs, Eva Frei, Volker M. Arlt, Václav Martínek, Heinz H. Schmeiser, The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases, Environmental and Molecular Mutagenesis, 2011, 52, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(433K)
    • References
25. 25
    Masaaki Moriya, Neda Slade, Branko Brdar, Zvonimir Medverec, Karla Tomic, Bojan Jelaković, Lin Wu, Sim Truong, Andrea Fernandes, Arthur P. Grollman, TP53 Mutational signature for aristolochic acid: an environmental carcinogen, International Journal of Cancer, 2011, 129, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(150K)
    • References
26. 26
    I Goldstein, V Marcel, M Olivier, M Oren, V Rotter, P Hainaut, Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies, Cancer Gene Therapy, 2011, 18, 1, 2

    CrossRef

27. 27
    S. Attaluri, R. R. Bonala, I.-Y. Yang, M. A. Lukin, Y. Wen, A. P. Grollman, M. Moriya, C. R. Iden, F. Johnson, DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells, Nucleic Acids Research, 2010, 38, 1, 339

    CrossRef

28. 28
    Jill E. Kucab, David H. Phillips, Volker M. Arlt, Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model, FEBS Journal, 2010, 277, 12, 2567

    CrossRef

29. 29
    Jill E. Kucab, David H. Phillips, Volker M. Arlt, Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model, FEBS Journal, 2010, 277, 12

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(503K)
    • References
30. 30
    Snezana Radisavljevic, Amira Peco-Antic, Jelena Kotur-Stevuljevic, Olivera Savic, Structural and functional characteristics of urinary tract in offspring of Balkan endemic nephropathy patients, Srpski arhiv za celokupno lekarstvo, 2010, 138, 3-4, 204

    CrossRef

31. 31
    Nadiya Bakhiya, Volker M. Arlt, Andrew Bahn, Gerhard Burckhardt, David H. Phillips, Hansruedi Glatt, Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy, Toxicology, 2009, 264, 1-2, 74

    CrossRef

32. 32
    Gerd P. Pfeifer, Ahmad Besaratinia, Mutational spectra of human cancer, Human Genetics, 2009, 125, 5-6, 493

    CrossRef

33. 33
    Lynnette R Ferguson, Role of dietary mutagens in cancer and atherosclerosis, Current Opinion in Clinical Nutrition and Metabolic Care, 2009, 12, 4, 343

    CrossRef

34. 34
    Marie Stiborova, Eva Frei, Volker M. Arlt, Heinz H. Schmeiser, The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers, Biomedical Papers, 2009, 153, 1, 5

    CrossRef

35. 35
    Arthur P. Grollman, John Scarborough, Bojan Jelaković, 2009,

    CrossRef